Biofrontera AG Sponsored ADR 3Y Shareholders Equity Growth (per Share)

3Y Shareholders Equity Growth (per Share) of BFAGY for past 10 years: annual, quarterly and twelve month trailing (TTM) including 3Y Shareholders Equity Growth (per Share) growth rates and interactive chart.


Highlights and Quick Summary

  • Annual 3Y Shareholders Equity Growth (per Share) for 2021 was 102.63% (a 40.51% increase from previous year)
  • Annual 3Y Shareholders Equity Growth (per Share) for 2021 was 73.04% (a -601.99% decrease from previous year)
  • Annual 3Y Shareholders Equity Growth (per Share) for 2020 was -14.55% (a -52.17% decrease from previous year)
Visit stockrow.com/BFAGY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical 3Y Shareholders Equity Growth (per Share) of Biofrontera AG Sponsored ADR

Most recent 3Y Shareholders Equity Growth (per Share)of BFAGY including historical data for past 10 years.

Interactive Chart of 3Y Shareholders Equity Growth (per Share) of Biofrontera AG Sponsored ADR

Biofrontera AG Sponsored ADR 3Y Shareholders Equity Growth (per Share) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 102.63%
2020 -14.55%
2019 -17.17%
2018 72.11%
2017 -42.83%
2016 10.31%

Business Profile of Biofrontera AG Sponsored ADR

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic